What is IgA (Immunoglobulin A) nephropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is IgA Nephropathy

IgA nephropathy is the most common primary glomerulonephritis worldwide, characterized by mesangial dominant or co-dominant IgA deposits in the kidney, resulting from immune complexes containing galactose-deficient IgA1 that trigger progressive glomerular inflammation and can lead to end-stage kidney disease. 1, 2

Pathophysiology

The disease is driven by a specific immunologic cascade:

  • The hallmark is deposition of poorly O-glycosylated IgA1 (galactose-deficient IgA1) in the glomerular mesangium, which forms immune complexes with autoantibodies against these abnormal IgA1 molecules 3, 4

  • These immune complexes activate mesangial cells and trigger complement-mediated inflammation, leading to glomerular injury and progressive tubulointerstitial fibrosis 4, 5

  • Genetic susceptibility plays a significant role, with multiple risk loci identified in the major histocompatibility complex region, some of which are linked to mucosal immune defense against pathogens 6

Diagnostic Criteria

Kidney biopsy remains the gold-standard diagnostic test and is required for definitive diagnosis: 2, 3

  • Immunofluorescence microscopy must demonstrate mesangial dominant or co-dominant IgA deposits 1, 2

  • Electron microscopy typically reveals electron-dense deposits in the mesangium 1, 2

  • C3 complement is often present alongside IgA deposits, while C1q is less commonly found 1

  • Histological features using the MEST-C scoring system independently predict disease outcomes 3

Clinical Presentation and Prognosis

The disease affects individuals of all ages and accounts for 20-25% of prevalent kidney failure cases in most registries: 7

  • Patients with proteinuria >1 g/day, hypertension, and impaired renal function at diagnosis are at high risk for disease progression 1

  • The 15-year kidney survival rate from apparent disease onset typically exceeds 70%, though progression when it occurs is usually slow and indolent 8

  • Spontaneous remission of disease activity occurs in approximately 7% of patients 8

  • Hypertension develops in 50% of patients during the disease course 8

Disease Burden

IgA nephropathy represents a major global health challenge: 3, 6

  • It is the most prevalent form of primary glomerulonephritis reported worldwide 3, 4

  • In children, teenagers, and young adults, it is one of the most common causes of irreversible kidney damage 7

  • The disease carries a high lifetime risk of kidney failure, making it both a source of personal suffering and a major socioeconomic problem 7, 3

References

Guideline

IgA Nephropathy Pathogenesis and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IgA Nephropathy Diagnosis and Associations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

IgA nephropathy in adults-treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023

Research

IgA Nephropathy: Emerging Mechanisms of Disease.

Indian journal of nephrology, 2024

Research

Immunoglobulin A nephropathy: current progress and future directions.

Translational research : the journal of laboratory and clinical medicine, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.